SELF-TEST QUESTIONNAIRE PSORIASIS. Plaque a raised lesion where the diameter is greater than the thickness. Number 2

Similar documents
PDP SELF-TEST QUESTIONNAIRE PSORIASIS. Plaque a raised lesion where the diameter is greater than the thickness. Number 2

PDP SELF-TEST QUESTIONNAIRE

PDP SELF-TEST QUESTIONNAIRE LEG ULCERS. Ulcer Full thickness loss of epidermis and some dermis, which will heal with scarring.

PDP SELF-TEST QUESTIONNAIRE ECZEMAS. Number 1 THE CORE TUTORIALS IN DERMATOLOGY FOR PRIMARY CARE UPDATED PDP SELF-TEST QUESTIONNAIRE 2010

Psoriasis. What is Psoriasis? What causes psoriasis? Medical Topics Psoriasis

The role of the practice nurse in managing psoriasis in primary care

Difference Between Seborrheic Dermatitis and Psoriasis

PDP SELF-TEST QUESTIONNAIRE SKIN INFECTION AND INFESTATION

Psoriasis is a chronic, inflammatory, Prescribing in children

PSORIASIS BEST PRACTICE IN MANAGEMENT

TREATMENT OPTIONS FOR PSORIASIS. Sandra Hanlon Dermatology Senior Charge Nurse NHS Ayrshire and Arran 07/03/17

PSORIASIS PSORIASIS. Anatomic sites FACTS ABOUT PROSIASIS PSORIASIS 11/16/2017 STIGMATA OF PSORIASIS

Psoriasis management. A/Prof Amanda Oakley Dermatologist, Waikato

Phototherapy and Photochemotherapy Treatment (Ultraviolet A [PUVA] and B [UBV])

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Supplementary Tables. Psoriasis a

Psoriasis. Causes of Psoriasis

A Guide to Understanding. Psoriasis. Treatment and Management Options LIVING WITH. Psoriasis.

What is Psoriasis? Common Areas Affected. Type Who Does it Affect Characteristics

Psoriasis. Overview. Epidemiology. Epidemiology 08/08/2015. Dr Nigel Burrows Consultant Dermatologist Addenbrooke s Hospital

Psoriasis. Dermatology. History. Examination. Background. Objective. Discussion. Keywords: psoriasis; skin diseases. Philip Clarke

KEY MESSAGES. Psoriasis patients are more prone to cardiovascular diseases, stroke, lymphoma and non-melanoma skin cancers, and increased mortality.

Psoriasis: Causes, Symptoms, And Treatment

A SYSTEMATIC APPROACH TO DIAGNOSING SKIN CONDITIONS

Topical Calcipotriol Algorithm

It is estimated that about 26,000 new cases of

My Algorithm. Questions to ask. Do you or your family have a history of?... Allergic rhinitis, Sensitive skin, Asthma Skin Cancer

A systematic review of treatments for severe psoriasis Griffiths C E, Clark C M, Chalmers R J, Li Wan Po A, Williams H C

An otherwise healthy 12-year-old

TESTS AND TECHNIQUES WHICH, WHEN AND WHY?

Psoriasis Case presentation 2 Ahmad is 50 years old male came to the on call dermatologist with a 3 day history of feeling generally unwell and

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Supplementary Online Content

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

A Patient s Guide to. Treatments for Psoriatic Arthritis

Appendix 1: Frequently Asked Questions

A Patient s Guide to Psoriatic Arthritis

What you need to know about PSORIASIS. Psoriasis

Psoriatic arthritis FACTSHEET

Editors: Azura Mohd Affandi Fatimah `Afifah Alias Asmah Johar Roshidah Baba

Vulval dermatoses. Dr Fiona Lewis, Consultant Dermatologist St John s Institute of Dermatology, London & Heatherwood & Wexham Park Hospital, Slough

Efficacy of Concomitant Use of PUVA and Methotrexate in Disease Clearance Time in Plaque Type Psoriasis

A Pilot Study. Name of investigational product:

EXAMINING THE CRUCIAL COALITION BETWEEN DERMATOLOGY AND RHEUMATOLOGY IN PSORIATIC ARTHRITIS

OCCG SERVICE SPECIFICATION (2017/18)

Psoriasis. Jessica Kaffenberger, M.D. Assistant Professor of Dermatology Division of Dermatology The Ohio State University Wexner Medical Center

Request for Special Authorization Enbrel

Corporate Medical Policy

Psoriasis. Andrei Metelitsa, MD, FRCPC, FAAD Clinical Associate Professor, Dermatology, U of C Co-Director, Institute for Skin Advancement

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSION PATHOLOGY OF THE SKIN LAB. Friday, February 13, :30 am 11:00 am

Retrospective 10 years review of 100 patients with psoriasis in the Kingdom of Saudi Arabia (KSA)

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Proposed Health Technology Appraisal

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSION PATHOLOGY OF THE SKIN LAB. Friday, February 12, :30 am 11:00 am

Acne, Eczema and Psoriasis. Dr Rebecca Clapham

Ontario Public Drug Programs. Inflectra (infliximab) Frequently Asked Questions

Predicting the Response to Phototherapy for Psoriasis Patients

Psoriasis the latest recommendations for management: where can primary care make a real difference?

Lamellar ichthyosis What Is ichthyosis? Classification of Lamellar Ichthyosis What is Lamellar Ichthyosis? What are the signs?

Dermatology Literary Review

ustekinumab (Stelara )

Subject: Remicade (Page 1 of 5)

Humira (adalimumab) DRUG.00002

Inflectra Frequently Asked Questions

2. Has the patient had a response to treatment? Y N. 3. Does the patient have a diagnosis of rheumatoid arthritis (RA)? Y N

ETANERCEPT Generic Brand HICL GCN Exception/Other ETANERCEPT ENBREL GUIDELINES FOR USE INITIAL CRITERIA (NOTE: FOR RENEWAL CRITERIA SEE BELOW)

2018 ReachMD Page 1 of 10

Psoriasis is an inflammatory condition of the skin that

Integumentary System

Circle Yes or No Y N. [If no, skip to question 7.] 2. Does the patient have a diagnosis of ulcerative colitis? Y N. [If no, skip to question 4.

Diphencyprone (DPC) treatment for Alopecia Areata

Dermatology elective for yr. 5. Natta Rajatanavin, MD. Div. of dermatology Dep. Of Medicine, Ramathibodi Hospital Mahidol University 23 rd Feb 2015

Dermatology GP Referral Guidelines

Some skin conditions

Cyltezo (adalimumab-adbm) CG-DRUG-64, CG-DRUG-65

Nail Psoriasis. A positive approach. to psoriasis and. psoriatic arthritis

Nails Examination and Disorders. Overview. Case 1 15/09/2016. Samantha Eisman. 25 year old woman Noticed at pedicure Single toe

Ustekinumab (Stelara )

TRANSPARENCY COMMITTEE OPINION. 26 April 2006

Cigna Drug and Biologic Coverage Policy

Is Apremilast (Otezla) Effective in Reducing Pruritus in Adults over 18 Years Old with Plaque Psoriasis?

Understanding Psoriatic Arthritis

Ministry of Health Malaysia. NATIONAL DERMATOLOGY REGISTRY (DermReg) The First Annual Report of the MALAYSIAN PSORIASIS REGISTRY

COPYRIGHTED MATERIAL. Introduction CHAPTER 1. Introduction

Recognizing common Dermatologic conditions. Case presentations. CAPA 2015 Annual Conference. Tanya Nino, MD St. Joseph Heritage Medical Group

Volume 7, Edition 1 / Winter 07 93

The Integumentary System. Chapter 6

The Natural History of Psoriasis and Treatment Goals

A study of treatment modalities in psoriasis in dermatology outpatient department of a tertiary care teaching hospital

Rashes Not To Be Missed In Children

Tejinder Kaur; Rajesh Rani Gupta; BB Mahajan; Rajiv Sachdeva

Diagnosis And Treatment Of Seborrheic Dermatitis

Follow this and additional works at: Part of the Skin and Connective Tissue Diseases Commons

Oral PUVA Phototherapy

Steroid use in managing your child s Atopic Eczema

DERMCASE. Swelling of the Face. Case White Toenails p Skin Papules p Patches of Hair p.34

1 P a g e. Systemic Juvenile Idiopathic Arthritis (SJIA) (1.3) Patients 2 years of age and older with active systemic juvenile idiopathic arthritis.

WHAT CAUSES PSORIASIS TO FLARE UP WHAT CAUSES PSORIASIS TO PDF PSORIASIS PSORIATIC ARTHRITIS MEDLINEPLUS

Comparative study of oral methotrexate and acitretin in the treatment of palmoplantar psoriasis

Transition for Children and Young People (age 0-18 years) with Diabetes

Transcription:

Number 2 CORE TUTORIALS IN DERMATOLOGY FOR PRIMARY CARE PDP SELF-TEST QUESTIONNAIRE AYERS ROCK, ULURU PSORIASIS NATIONAL PARK, AUSTRALIA Plaque a raised lesion where the diameter is greater than the thickness

CORE TUTORIALS IN DERMATOLOGY FOR PRIMARY CARE AUTHOR: DR BRIAN MALCOLM, BSc, MBChB, DRCOG, DPD, DCH, MRCGP, Dip Derm (Glasg.). GENERAL PRACTITIONER, LITCHDON MEDICAL CENTRE, BARNSTAPLE. ASSOCIATE SPECIALIST, NORTH DEVON HEALTHCARE TRUST. PDP SELF-TEST QUESTIONNAIRE INTRODUCTION This self-test questionnaire has been written by Dr Brian Malcolm, based on Chapter 2 Psoriasis of the Core Tutorials in Dermatology for Primary Care. This Chapter was the second of a series, which was sent out to health professionals with the compliments of Dermal Laboratories. If you are no longer in possession of this Chapter, you can order a replacement copy from Dermal at the address below. This self-test questionnaire has been designed so that it can be incorporated within your Personal Development Plan (PDP) folder. Having read the relevant Chapter, complete questions 1 to 12. After completing the questionnaire, you can find the information for answers 1 to 10 on the last two pages of the booklet. RESOURCES FOR MANAGING PSORIASIS AVAILABLE FROM DERMAL TRIAL PACKS Topical treatments are literally worn on the skin of the patient. What feels good for one patient may not be acceptable to another, especially when it comes to emollients, which tend to be used for long periods and involve large areas. To assist with patient compliance, trial packs are available on request to health professionals. PATIENT EDUCATION To encourage better understanding of the importance of emollients for dry skin disorders such as psoriasis, a pad of patient information leaflets is available. Also available are patient booklets explaining how to use short contact Dithrocream therapy to best effect. You and Your Scalp booklets are available to explain about scaly scalp conditions and how to use Capasal Therapeutic Shampoo. To request a supply of any of the above items, contact Dermal at the address below. SPONSORED BY DERMAL LABORATORIES, TATMORE PLACE, GOSMORE, HITCHIN, HERTS, SG4 7QR, UK. TELEPHONE: 01462 458866. WWW.DERMAL.CO.UK

QUESTIONS 1. If a parent has psoriasis what is the risk of a child developing the same problem? 2. How commonly do nail changes coexist with skin involvement of psoriasis? 3. What is the Koebner phenomenon? 4. Name 3 distinct patterns of psoriatic arthropathy. 5. Name four different drugs used systemically for more difficult psoriasis.

QUESTIONS 6. What class of drug is Dovonex (calcipotriol)? 7. From what natural source is dithranol derived? 8. What percentage of psoriatics improve with exposure to the sun? 9. What is the Auspitz sign? 10. What is strongly associated with the development of palmoplantar pustular psoriasis?

REFLECTIVE LEARNING 11. What did I find useful about the learning module on Psoriasis? 12. Having reflected on this module, how might my practice change in managing psoriasis?

ANSWERS (PLEASE TURN UPSIDE DOWN) QUESTION 6. Ref page 9 Vitamin D analogues. They are thought to work by normalizing cell growth inhibiting cell proliferation and inducing cell differentiation. The importance of twice daily application should be emphasized to improve response. QUESTION 7. Ref page 8 Dithranol (anthralin) - This is a synthetic derivative of a naturally occurring substance chrysarobin which, in turn, is derived from the bark of a Brazilian tree. This preparation has been in use for the treatment of stable plaque psoriasis since 1912. QUESTION 8. Ref page 11 Natural sunlight improves psoriasis in 85% of patients affected. QUESTION 9. Ref page 4 Psoriasis is essentially a clinical diagnosis. There is little need for further investigation and useful tips in confirming diagnosis include gently scraping a plaque which will accentuate the silvery scale, while more vigorous scraping will lead to characteristic pin point capillary bleeding the so called Auspitz sign, but beware HIV! QUESTION 10. Ref page 3 Palmoplantar pustulosis This is a rarer presentation of localised pustulation involving the thickened epidermis of the palms of the hands and soles of the feet which can be very disabling due to painful fissuring. It can be differentiated from pompholyx eczema by the dominance of pustulation rather than sago grain vesiculation. It is a notoriously stubborn condition to treat, more commonly occurring in females and has a strong association with cigarette smoking. An associated extreme form of destructive nail and terminal phalangeal involvement called acropustulosis can be enormously disabling.

ANSWERS QUESTION 1. Ref page 1 There is a large subpopulation of genetically predisposed individuals whose psoriasis is triggered by factors both known and unknown. Inheritance is polygenic but one possible likely pattern is autosomal dominance with incomplete penetrance. There are a number of HLA associations. There is a positive family history in one third of sufferers. This is less likely in late onset psoriasis. If one parent is affected there is a 10 25% risk to the child, and if both parents are affected the risk increases from 50 60%. QUESTION 2. Ref page 3 Nail changes are also common, occurring in up to 50% of patients, with a characteristic triad of pitting, subungual keratosis and onycholysis often in a symmetrical distribution. When nail involvement is the sole presentation, the presence of pitting is enormously useful to distinguish psoriasis from fungal nail dystrophy. Ref page 11 There is no simple effective topical treatment for nail psoriasis. The presence of pitting reliably differentiates between fungal and psoriatic nail dystrophy, although these of course can coexist! QUESTION 3. Ref page 4 Psoriasis also illustrates the Koebner phenomenon following lines of trauma such as surgical scars or scratch marks. This phenomenon is shared by one or two other common dermatoses, most notably lichen planus and viral warts. QUESTION 4. Ref page 5 There is an associated seronegative arthritis in 7 10% of patients. This is closely associated with HLA B27 tissue typing. There are some very distinct patterns of joint involvement: symmetrical polyarthropathy similar to rheumatoid arthritis; oligoarthropathy with one of more large joints involved; sacroileitis; mutilans as the name suggests a very severe and destructive form of arthritis. QUESTION 5. Ref page 6 Consultant dermatologists vary tremendously in their enthusiasm for second line treatments, both with phototherapy and, more particularly, with DMARDs (Disease modifying anti-rheumatoid drugs) methotrexate, cyclosporin, azathioprine, hydroxyurea and acitretin. Side effects can be hazardous. Often monitoring can be done in an exemplary fashion and still significant morbidity arise....the GP should have a working knowledge of these drugs and their common side effects and interactions. In many parts of the country, the GPs are closely involved in monitoring DMARDs with interval blood tests; in others this is seen as exclusively a specialist responsibility.